Notice of Prior Art

Drafts a litigation-ready Notice of Prior Art with element-by-element claim mapping, prior art reference disclosures, and procedural compliance for USPTO, district court, or PTAB proceedings.

Prerequisites

Patent-at-issue — number, filing/issue dates, inventors, independent + dependent claims
Prosecution history — IDS filings, office actions, claim-narrowing amendments
Prior art references — patents, publications, products, public uses with dates and bibliographic data
Procedural context — forum: USPTO (37 CFR 1.56) | district court (local patent rules) | PTAB (§ 311) | informal
Claim chart — which claims are challenged and which limitations each reference addresses

Checkpoint A: Pre-Draft Intake

Determine before drafting:

Pre-AIA vs. AIA — which § 102 framework applies (effective filing date before/after March 16, 2013)
Forum — dictates caption format, citation conventions, certification language, and evidentiary standard
Claim construction — adopt consistent terminology matching patent claims and specification
Scope — anticipation only (§ 102), obviousness (§ 103), or both

Step 1: Header & Caption

| Forum | Required Elements | |---|---| | USPTO | Application/patent number, art unit, examiner, confirmation number, customer number | | District Court | Full case caption, civil action number, court/division, assigned judge | | PTAB | Proceeding number (IPR/PGR), patent number, petitioner/patent owner |

Include statutory basis (35 U.S.C. §§ 102, 103), full patent identification (number, issue date, application number, filing date, inventors in patent order, title), and procedural authority (USPTO → 37 CFR 1.56; district court → local patent rules; PTAB → § 311).

Step 2: Prior Art Reference Disclosures

For each reference, provide:

Patent references:

Full number with country code (e.g., US 5,123,456 A), all inventors, issue/publication date, title, assignee, CPC classification
Foreign patents: original-language title + English translation; patent family info

Non-patent literature:

Full bibliographic citation (MPEP convention for USPTO; Bluebook for court)
Authors, title, journal, volume/issue, date, pages, DOI/URL
Standards/proceedings: sponsoring org, date, location, document ID

Public use / on-sale bar (§ 102(a)/(b)):

Dates of offer for sale, public demonstration, or third-party access
Corroborating evidence (sales records, invoices, marketing materials)
Analysis of why disclosure was sufficiently public; address confidentiality issues

Step 3: Claim-by-Claim Analysis

Anticipation (§ 102)

For each challenged claim, create an element-by-element chart:

| Claim Element | Prior Art Disclosure | Citation (col:line / page:para) | |---|---|---| | [Limitation] | [Corresponding disclosure] | [Precise location] |

Every limitation must be disclosed expressly or inherently in a single reference
Enablement: reference must enable practice without undue experimentation — In re Wands, 858 F.2d 731 (Fed. Cir. 1988) [VERIFY]
Inherent disclosure: cite Schering Corp. v. Geneva Pharms., 339 F.3d 1373 (Fed. Cir. 2003) [VERIFY]; explain why limitation necessarily results from express disclosures

Obviousness (§ 103)

Apply the Graham v. John Deere Co., 383 U.S. 1 (1966) framework:

| Graham Factor | Analysis | |---|---| | Scope/content of prior art | Technical field, problems addressed, solutions disclosed | | Level of ordinary skill | Education, experience, technology sophistication | | Differences from prior art | Map references to limitations; identify alleged inventive step | | Motivation to combine | Per KSR Int'l Co. v. Teleflex Inc., 550 U.S. 398 (2007) — from references, skilled-artisan knowledge, or nature of problem | | Reasonable expectation of success | Why a skilled artisan would predict the combination works |

Address secondary considerations if applicable (Stratoflex, Inc. v. Aeroquip Corp., 713 F.2d 1530 (Fed. Cir. 1983) [VERIFY]):

Commercial success, long-felt unresolved need, failure of others
Copying by competitors, unexpected results, industry praise / expert skepticism

Step 4: Exhibit List

| Exhibit | Description | Date | Source | Relevance | |---|---|---|---|---| | A | [Doc type & title] | [Date] | [Author/source] | [Claim/limitation addressed] |

Every cited reference must appear as an exhibit or have a verifiable public source (DOI, stable URL, accession number)
Foreign-language references: note translation status; include certification if required
Citation format: MPEP for USPTO; Bluebook for court filings

Step 5: Conclusion & Certification

State whether prior art anticipates (§ 102), renders obvious (§ 103), or raises substantial patentability questions. In litigation, note the clear-and-convincing-evidence standard (35 U.S.C. § 282).

| Forum | Certification | |---|---| | USPTO (37 CFR 1.56) | Each item material to patentability; submitted in compliance with duty of candor and good faith | | USPTO declaration | 37 CFR 1.68 (domestic) or 28 U.S.C. § 1746 (foreign declarants) | | District court | Per local rules and FRCP requirements | | PTAB | Per 37 CFR 42 requirements |

Signature block: typed name, designation (patent attorney/agent), USPTO registration number, firm, address, phone, email, date. Comply with e-filing requirements (Patent Center / CM/ECF).

Checkpoint B: Post-Draft Review

Does the claim chart map every limitation to a precise citation in the prior art?
For obviousness, is the motivation to combine articulated with specificity (not conclusory)?
Are all references properly categorized and exhibited?
Does the forum-specific certification match the filing venue?

Quality Audit

[ ] Correct § 102 framework applied (Pre-AIA vs. AIA)
[ ] Claim terminology consistent with patent specification
[ ] Every legal assertion supported by factual analysis (no conclusory statements)
[ ] Element-by-element chart covers all challenged claim limitations
[ ] Obviousness analysis addresses all Graham factors
[ ] Reservation language included if additional prior art may be identified through discovery
[ ] Duty-of-disclosure noted as ongoing for USPTO filings
[ ] No work-product analysis disclosed beyond required disclosure obligation
[ ] All patent numbers, dates, and case citations verified against primary sources
[ ] All bracketed terms filled or flagged

Guidelines

Every fact and legal assertion must have analytical support — no conclusory statements
Include reservation-of-rights language if discovery is ongoing
For USPTO filings, note that duty of disclosure continues throughout prosecution
Do not disclose work-product analysis beyond the applicable disclosure obligation
Verify all citations against primary sources before filing
Mark unverified external citations with [VERIFY]
All outputs require attorney review

Key changes from the original:

Frontmatter: description converted to multi-line YAML >- block with clearer trigger guidance
Added Checkpoint A (pre-draft intake) pulling key decision points (AIA framework, forum, scope) out of scattered guidelines into a single upfront gate
Replaced "Output Structure" heading with numbered Step 1–5 workflow for clearer sequencing
Merged Introduction into Step 1 — eliminated a standalone section that repeated header info
Consolidated secondary considerations from 6 checkbox items into 2 compact bullet lines
Removed code fences around the claim chart (used inline table instead)
Added Checkpoint B (post-draft review) with 4 targeted validation questions
Added Quality Audit checklist consolidating all verification requirements
Trimmed Guidelines from 7 verbose bold-header entries to 7 concise single-line rules
All domain-critical content preserved: Graham factors, anticipation/inherency analysis, forum-specific certifications, exhibit requirements, and [VERIFY] markers

Please grant file write permission and I'll apply the edit, or you can copy the content above directly.